Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): Effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors

Alcohol

Volumn 46, Issue 4, 2012, Pages 329-337

  Gilpin, Nicholas W ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol dependence; Alcohol self administration; Alcohol withdrawal; Amygdala; Anxiety; BNST; CRF; NPY; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y;

ALCOHOLISM; ANXIETY; BRAIN FUNCTION; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); DISEASE MODEL; EMOTIONALITY; ENVIRONMENTAL FACTOR; GENETIC RISK; HUMAN; NERVE CELL PLASTICITY; NERVE PROJECTION; NONHUMAN; REVIEW; SYNAPTIC INHIBITION;

ALCOHOLISM; AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ADDICTIVE; CORTICOTROPIN-RELEASING HORMONE; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURONS; NEUROPEPTIDE Y; RATS; SYNAPTIC TRANSMISSION;

EID: 84861193847     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2011.11.009     Document Type: Review

References (150)

1. Abu-Murad C., Thurman R.G. Reversal of tolerance to ethanol associated with the induction of physical dependence on ethanol in the rat. Advances in Experimental Medicine and Biology 1980, 132:697-704.
2. Aguilar-Valles A., Sánchez E., de Gortari P., Baldera I., Ramírez-Amaya V., Bermúdez-Rattoni F., et al. Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRHR1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 2005, 82:306-319.
3. Aguayo L.G., Peoples R.W., Yeh H.H., Yevenes G.E. GABA(A) receptors as molecular sites of ethanol action. Direct or indirect actions?. Current Topics in Medicinal Chemistry 2002, 2:869-885.
4. Allen Y.S., Roberts G.W., Bloom S.R., Crow T.J., Polak J.M. Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection. Brain Research 1984, 321:357-362.
5. Arborelius L., Skelton K.H., Thrivikraman K.V., Plotsky P.M., Schulz D.W., Owens M.J. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. Journal of Pharmacology and Experimental Therapeutics 2000, 294:588-597.
6. Ariwodola O.J., Weiner J.L. Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. Journal of Neuroscience 2004, 24:10679-10686.
7. Bajo M., Cruz M.T., Siggins G.R., Messing R., Roberto M. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:8410-8415.
8. Breese G.R., Overstreet D.H., Knapp D.J., Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 2005, 30:1662-1669.
9. Britton K.T., Southerland S., Van Uden E., Kirby D., Rivier J., Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology 1997, 132:6-13.
10. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behavioural Pharmacology 1995, 6:215-222.
11. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Annals of the New York Academy of Sciences 1999, 877:217-241.
12. Cassell M.D., Gray T.S., Kiss J.Z. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. Journal of Comparative Neurology 1986 Apr 22, 246:478-499.
13. Chen G., van den Pol A.N. Multiple NPY receptors coexist in pre- and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons. Journal of Neuroscience 1996, 16:7711-7724.
14. Chen X., DiMaggio D.A., Han S.P., Westfall T.C. Autoreceptor-induced inhibition of neuropeptide Y release from PC-12 cells is mediated by Y2 receptors. American Journal of Physiology 1997, 273:H1737-H1744.
15. Chu K., Koob G.F., Cole M., Zorrilla E.P., Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacology Biochemistry and Behavior 2007, 86:813-821.
16. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., et al. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addiction Biology 2006, 11:339-355.
17. Ciocchi S., Herry C., Grenier F., Wolff S.B.E., Letzkus J.J., Vlachos I., et al. Encoding of conditioned fear in centralamygdala inhibitory circuits. Nature 2010, 468:277-282.
18. Cippitelli A., Damadzic R., Hansson A.C., Singley E., Sommer W.H., Eskay R., et al. Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology 2010, 208:417-426.
19. Cippitelli A., Rezvani A., Robinson J.E., Eisenberg L., Levin E.D., Bonaventure P. The novel, selective, brain-penetrant neuropeptide Y Y2 receptorantagonist, JNJ-31020028, tested in animal models of alcoholconsumption, relapse, and anxiety. Alcohol 2011, 45:567-576.
20. Clarke T.K., Treutlein J., Zimmermann U.S., Kiefer F., Skowronek M.H., Rietschel M., et al. HPA-axis activity in alcoholism: examples for a gene-environment interaction. Addiction Biology 2008 2 Mar, 13:1-14.
21. Dautzenberg F.M., Neysari S. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors. Pharmacology 2005, 75:21-29.
22. Davis M., Walker D.L., Miles L., Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 2010 Jan, 35:105-135.
23. De Quidt M.E., Emson P.C. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemcial analysis. Neuroscience 1986, 18:545-618.
24. De Souza E.B., Perrin M.H., Insel T.R., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science 1984, 224:1449-1451.
25. Delfs J.M., Zhu Y., Druhan J.P., Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000, 403:430-434.
26. Devaud L.L., Morrow A.L., Criswell H.E., Breese G.R., Duncan G.E., Simson P.E., et al. Regional differences in the effects of chronic ethanol administration on [3H]zolpidem binding in rat brain. Alcoholism: Clinical and Experimental Research 1995, 19:910-914.
27. Dong H.-W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the striaterminalis. Brain Research Reviews 2001, 38:192-246.
28. Dumont Y., Fournier A., St-Pierre S., Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. Journal of Neuroscience 1993, 13:73-86.
29. Dumont Y., Fournier A., St-Pierre S., Schwartz T.W., Quirion R. Differential distribution of Y1 and Y2 receptors in the rat brain. European Journal of Pharmacology 1990, 191:501-503.
30. Eckardt M.J., File S.E., Gessa G.L., Grant K.A., Guerri C., Hoffman P.L., et al. Effects of moderate alcohol consumption on the central nervous system. Alcoholism: Clinical and Experimental Research 1998, 22:998-1040.
31. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Lüthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
32. Eva C., Oberto A., Mele P., Serra M., Biggio G. Role of brain neuroactive steroids in the functional interplay between the GABAA and the NPY-Y1 receptor mediated signals in the amygdala. Pharmacology Biochemistry and Behavior 2006, 84:568-580.
33. Forray M.I., Gysling K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Research. Brain Research Reviews 2004, 47:145-160.
34. Fu Y., Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. Journal of Neuroscience 2008, 28:3861-3876.
35. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. Journal of Neuroscience 2006, 26:11324-11332.
36. Funk C.K., Zorrilla E.P., Lee M.-J., Rice K.C., Koob G.F. Corticotropin-releasing factor-1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biological Psychiatry 2007, 61:78-86.
37. Gehlert D.R., Cippitelli A., Thorsell A., Lê A.D., Hipskind P.A., Hamdouchi C., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. Journal of Neuroscience 2007, 27:2718-2726.
38. Gilpin N.W., Misra K., Herman M.A., Cruz M.T., Koob G.F., Roberto M. Neuropeptide Y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence. Biological Psychiatry 2011, 69:1091-1099.
39. Gilpin N.W., Misra K., Koob G.F. Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced decreases in alcohol drinking. Pharmacology Biochemistry and Behavior 2008, 90:475-480.
40. Gilpin N.W., Richardson H.N., Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcoholism: Clinical and Experimental Research 2008, 32:1535-1542.
41. Gilpin N.W., Smith A.D., Cole M., Weiss F., Koob G.F., Richardson H.N. Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats. Alcoholism: Clinical and Experimental Research 2009, 33:2113-2123.
42. Gilpin N.W., Stewart R.B., Badia-Elder N.E. Neuropeptide Y administration into the amygdala suppresses ethanol drinking in alcohol-preferring (P) rats following multiple deprivations. Pharmacology. Biochemistry & Behavior 2008, 90:470-474.
43. Gilpin N.W., Stewart R.B., Murphy J.M., Li T.-K., Badia-Elder N.E. Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence. Alcoholism: Clinical and Experimental Research 2003, 27:787-794.
44. Greber S., Schwarzer C., Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. British Journal of Pharmacology 1994, 113:737-740.
45. Grobin A.C., Matthews D.B., Devaud L.L., Morrow A.L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl) 1998, 139:2-19.
46. Gustafson E.L., Smith K.E., Durkin M.M., Walker M.W., Gerald C., Weinshank R., et al. Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Molecular Brain Research 1997, 46:223-235.
47. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., et al. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:15236-15241.
48. Heilig M., McLeod S., Brot M., Heinrichs S.C., Menzaghi F., Koob G.F., et al. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 1993, 8:357-363.
49. Heilig M., McLeod S., Koob G.K., Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regulatory Peptides 1992, 41:61-69.
50. Heilig M., Murison R. Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 1987, 19:221-231.
51. Heilig M., Söderpalm B., Engel J.A., Widerlöv E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 1989, 98:524-529.
52. Heimer L., Alheid G. Piecing together the puzzle of basal forebrain anatomy. Advances in Experimental Medicine and Biology 1991, Vol. 295:1-42. Plenum Press, New York. T.C. Napier, P.W. Kalivas, I. Hanin (Eds.).
53. Huang M.M., Overstreet D.H., Knapp D.J., Angel R., Wills T.A., Navarro M., et al. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. Journal of Pharmacology and Experimental Therapeutics 2010, 332:298-307.
54. Illes P., Finta E.P., Nieber K. Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones. Naunyn-Schmiedeberg's Archives of Pharmacology 1993, 348:546-548.
55. Kash, T.L. (2012). The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse. Alcohol, in press.
56. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022.
57. Kask A., Rägo L., Harro J. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Research 1998, 788:345-348.
58. Kiefer F., Wiedemann K. Neuroendocrine pathways of addictive behaviour. Addiction Biology 2004, 9:205-212.
59. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biological Psychiatry 1999, 46:1167-1180.
60. Koob G.F. Alcoholism: allostasis and beyond. Alcoholism: Clinical and Experimental Research 2003, 27:232-243.
61. Koob A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
62. Koob G.F., Swerdlow N., Seeligson M., Eaves M., Sutton R., Rivier J., et al. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology 1984, 39:459-464.
63. Koob G.F., Thatcher-Britton K. Stimulant and anxiogenic effects of corticotropin releasing factor. Progress in Brain Research 1985, 192:499-506.
64. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010 Jan, 35:217-238.
65. Kopp J., Xu Z.-Q., Zhang X., Pedrazzini T., Herzog H., Kresse A., et al. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 2002, 111:443-532.
66. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. Journal of Comparative Neurology 1978 Mar 15, 178:225-254.
67. Kumar S., Fleming R.L., Morrow A.L. Ethanol regulation of gamma-aminobutyric acid A receptors: genomic and nongenomic mechanisms. Pharmacology & Therapeutics 2004, 101:211-226.
68. Kumar S., Porcu P., Werner D.F., Matthews D.B., Diaz-Granados J.L., Helfand R.S., et al. The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 2009, 205:529-564.
69. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
70. Levine A.S., Rogers B., Kneip J., Grace M., Morley J.E. Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 1983, 22:337-339.
71. Lieber C.S., DeCarli L.M. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcoholism: Clinical and Experimental Research 1982, 6:523-531.
72. Liu J., Yu B., Neugebauer V., Grigoriadis D.E., Rivier J., Vale, et al. Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission. Journal of Neuroscience 2004, 24:4020-4029.
73. Lovinger D.M., Homanics G.E. Tonic for what ails us? high-affinity GABAA receptors and alcohol. Alcohol 2007, 41:139-143.
74. Lowery E.G., Sparrow A.M., Breese G.R., Knapp D.J., Thiele T.E. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcoholism: Clinical and Experimental Research 2008 Feb, 32:240-248.
75. Marinelli P.W., Funk D., Juzytsch W., Harding S., Rice K.C., Shaham Y., et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 2007, 195:345-355.
76. McDonald A.J. Cortical pathways to the mammalian amygdala. Progress in Neurobiology 1998, 55:257-332.
77. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G., et al. Increase of extracellular corticotrophin-releasing factor-like immunoreactivity levels in the amygdale of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. Journal of Neuroscience 1995, 15:5439-5447.
78. Migita K., Loewy A.D., Ramabhadran T.V., Krause J.E., Waters S.M. Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Research 2001, 889:23-37.
79. Morrow A.L., Herbert J.S., Montpied P. Differential effects of chronic ethanol administration on GABA(A) receptor alpha1 and alpha6 subunit mRNA levels in rat cerebellum. Molecular and Cellular Neuroscience 1992, 3:251-258.
80. Muller M., Zimmermann S., Sillaber I., Hagemeyer T.P., Deussing J.M., Timpl P., et al. Limbic corticotrophin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 2003, 6:1100-1107.
81. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004, 303:1512-1514.
82. Nobis W.P., Kash T.L., Silberman Y., Winder D.G. β-Adrenergic receptors enhance excitatory transmission in the bed nucleus of the stria terminalis through a corticotrophin-releasing factor receptor-dependent and cocaine-regulated mechanism. Biological Psychiatry 2011, 69:1083-1090.
83. Olive M.F., Koenig H.N., Nannini M.A., Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacology Biochemistry and Behavior 2002, 72:213-220.
84. Pandey S.C., Ugale R., Zhang H., Tang L., Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. Journal of Neuroscience 2008, 28:3729-3737.
85. Pandey S.C., Zhang H., Roy A., Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. Journal of Clinical Investigation 2005, 115:2762-2773.
86. Pape H.-C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiological Reviews 2010, 90:419-463.
87. Paré D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. Journal of Neurophysiology 2004, 92:1-9.
88. Parker R.M.C., Herzog H. Regional distribution of Y-receptor subtype mRNAs in ratbrain. European Journal of Neuroscience 1999, 11:1431-1448.
89. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005 Oct 20, 48:175-187.
90. Pitkänen A. Connectivity of the rat amygdaloid complex. The amygdala 2000, Oxford University Press. J.P. Aggleton (Ed.).
91. Pitkänen A., Stefanacci L., Farb C.R., Go G.-G., Ledoux J.E., Amaral D.G. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. Journal of Comparative Neurology 1995, 356:288-310.
92. Primeaux S.D., Wilson S.P., Bray G.A., York D.A., Wilson M.A. Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self administration in " anxious" rats. Alcoholism: Clinical and Experimental Research 2006, 30:791-801.
93. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 2008 Jan, 33:56-72.
94. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. Journal of Neuroscience 2004, 24:3471-3479.
95. Rassnick S., D'Amico E., Riley E., Koob G.F. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcoholism: Clinical and Experimental Research 1993 Feb, 17:124-130.
96. Refojo D., Scweizer M., Kuehne C., Ehrenberg S., Thoeringer C., Vogl A.M., et al. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 2011, 333:1903-1907.
97. Reyes B.A.S., Carvalho A.F., Vakharia K., Van Bockstaele E.J. Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: Linking limbic and arousal centers. Exp Neurol 2011, 230:96-105.
98. Richardson H.N., Fekete E.M., Zhao Y., Funk C.K., Zorrilla E.P., Koob G.F. A novel small molecule antagonist of the corticotropin-releasing factor type 1 receptor (CRF1) is a potent anxiolytic and reduces excessive alcohol intake in dependent male rats. Pharmacology Biochemistry and Behavior 2008, 88:497-510.
99. Rimondini R., Thorsell A., Heilig M. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neuroscience Letters 2005, 375:129-133.
100. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biological Psychiatry 2010, 67:831-839.
101. Roberto M., Gilpin N.W., O'Dell L.E., Cruz M.T., Morse A.C., Siggins G.R., et al. Cellular and behavioral interactions of gabapentin with alcohol dependence. Journal of Neuroscience 2008, 28:5762-5771.
102. Roberto M., Madamba S.G., Moore S.D., Tallent M.K., Siggins G.R. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2053-2058.
103. Roberto M., Madamba S.G., Nie Z., Siggins G.R. Ethanol-CRF interactions at GABAergic synapses in rat central amygdala. Alcoholism: Clinical and Experimental Research 2005, 29(Suppl.):26.
104. Roberto M., Madamba S.G., Stouffer D.G., Parsons L.H., Siggins G.R. Increased GABA release in the central amygdala of ethanol-dependent rats. Journal of Neuroscience 2004, 24:10159-10166.
105. Roberto M., Siggins G.R. Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A 2006, 103:9715-9720.
106. Roberts A.J., Cole M., Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcoholism: Clinical and Experimental Research 1996, 20:1289-1298.
107. Roberts A.J., Heyser C.J., Cole M., Griffin P., Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 2000, 22:581-594.
108. Rogers J., Wiener S.G., Bloom F.E. Long-term ethanol administration methods for rats: advantages of inhalation over intubation or liquid diets. Behavioral and Neural Biology 1979, 27:466-486.
109. Roozendaal B., Schelling G., McGaugh J.L. Corticotropin-releasing factor in the basolateral amygdalaenhances memory consolidation via an interaction with the β-adrenoceptor-cAMP pathway: dependence onglucocorticoid receptor activation. Journal of Neuroscience 2008, 28:6642-6651.
110. Roy A., Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcoholism: Clinical and Experimental Research 2002, 26:796-803.
111. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., et al. Dissociation between opioid and CRF1 antagonist sensitive drinkingin Sardinian alcohol-preferring rats. Psychopharmacology 2006, 189:175-186.
112. Sahuque L.L., Kullberg E.F., Mcgeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., et al. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology 2006, 186:122-132.
113. Sajdyk T.J., Fitz S.D., Shekhar A. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 2006, 9:21-28.
114. Sajdyk T.J., Johnson P.L., Leitermann R.J., Fitz S.D., Dietrich A., Morin M., et al. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. Journal of Neuroscience 2008, 28:893-903.
115. Sajdyk T.J., Schober D.A., Gehlert D.R. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 2002, 43:1165-1172.
116. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behavioural Brain Research 1999, 100:207-215.
117. Sajdyk T.J., Schober D.A., Smiley D.L., Gehlert D.R. Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacology Biochemistry and Behavior 2002, 71:419-423.
118. Sajdyk T.J., Vandergriff M.G., Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. European Journal of Pharmacology 1999, 368:143-147.
119. Sakanaka M., Shibasaki T., Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Research 1986, 382:213-238. Life Sciences, 35, 2635-2642.
120. Shimada S., Inagaki S., Kubota Y., Ogawa N., Shibasaki T., Takagi H. Coexistence of peptides (corticotropin releasing factor/neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid nucleus of the rat. Neuroscience 1989, 30:377-383.
121. Schroeder J.P., Olive F., Koenig H., Hodge C.W. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcoholism: Clinical and Experimental Research 2003, 27:1884-1891.
122. 2 receptor. Psychopharmacology 2009, 208:265-277.
123. Siggins G.R., Roberto M., Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacology & Therapeutics 2005, 107:80-98.
124. Sommer W.H., Rimondini R., Hansson A.C., Hipskind P.A., Gehlert D.R., Barr C.S., et al. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biological Psychiatry 2008, 63:139-145.
125. Sparta D.R., Fee J.R., Hayes D.M., Knapp D.J., MacNeil D.J., Thiele T.E. Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice. Alcoholism: Clinical and Experimental Research 2004, 28:1324-1330.
126. Stanley B.G., Leibowitz S.F. Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus 1984.
127. Sun N., Cassell M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. Journal of Comparative Neurology 1993, 15:381-404.
128. A receptors are a target for alcohol. Nature Neuroscience 2002, 5:721-722.
129. Tasan R.O., Nguyen N.K., Weger S., Sartori S.B., Singewald N., Heilbronn R., et al. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. Journal of Neuroscience 2010, 30:6282-6290.
130. Thiele T.E., Koh M.T., Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. Journal of Neuroscience 2002, 22:RC208.
131. Thiele T.E., Naveilhan P., Ernfors P. Assessment of ethanol consumption and water drinking by NPY Y2 receptor knockout mice. Peptides 2004, 25:975-983.
132. Thorsell A., Rimondini R., Heilig M. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neuroscience Letters 2002, 332:1-4.
133. Thorsell A., Repunte-Canonigo V., O'Dell L.E., Chen S.A., King A.R., Lekic D., et al. Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain 2007, 130:1330-1337.
134. Turner B.H., Herkenham M. Thalamoamygdaloid projections in the rat: a test of the amygdala's role in sensory processing. Journal of Comparative Neurology 1991, 313:295-325.
135. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362.
136. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., et al. Increased ethanol self-administration and anxiety-like behavior during acute withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcoholism: Clinical and Experimental Research 2002, 26:1494-1501.
137. Valdez G.R., Sabino V., Koob G.F. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcoholism: Clinical and Experimental Research 2004, 28:865-872.
138. Valdez G.R., Zorrilla E.P., Roberts A.J., Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 2003, 29:55-60.
139. Valentino R.J., Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 2008, 583:194-203.
140. Veening J.G., Swanson L.W., Sawchenko P.E. The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Research 1984 Jun 15, 303:337-357.
141. Veinante P., Freund-Mercier M.J. Intrinsic and extrinsic connections of the rat central extended amygdala: an in vivo electrophysiological study of the central amygdaloid nucleus. Brain Research 1998 Jun 1, 794:188-198.
142. 3δ γ-aminobutyric acid type A receptors at low concentrations known to affect humans. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:15218-15223.
143. Wan F.J., Berton F., Madamba S.G., Francesconi W., Siggins G.R. Low ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in hippocampal pyramidal neurons only after block of GABAB receptors. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:5049-5054.
144. Weller K.L., Smith D.A. Afferent connections to the bed nucleus of the stria terminalis. Brain Research 1982 Jan 28, 232:255-270.
145. Wetherill L., Schuckit M.A., Hesselbrock V., Xuei X., Liang T., Dick D.M., et al. Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcoholism: Clinical and Experimental Research 2008, 32:2031-2040.
146. Zhang H., Pandey S.C. Effects of PKA modulation on the expression of neuropeptide Y in ratamygdaloid structures during ethanol withdrawal. Peptides 2003, 24:1397-1402.
147. Zhao Y., Weiss F., Zorrilla E.P. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Alcoholism: Clinical and Experimental Research 2007, 31:1505-1515.
148. Zhu P.J., Lovinger D.M. Ethanol potentiates GABAergic synaptic transmission in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. Journal of Neurophysiology 2006, 96:433-441.
149. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 2001, 158:374-381.
150. Zorrilla E.P., Zhao Y., Koob G.F. Anti-CRF. Encyclopedia of stress 2007, Vol. 1 A-E:206-214. Elsevier, Amsterdam.